{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:29:08Z","timestamp":1790753348753,"version":"4.1.0"},"reference-count":28,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Family history of kidney disease increases risk of end-stage kidney disease (ESKD) in donors. Pre-donation genetic testing is recommended in evaluation guidelines and regulatory policy. Collaborating across several institutions, we describe cases to illustrate the utility as well as practical issues in incorporating genetic testing in transplant protocols. Case 1 is from 2009, before pervasive genetic testing. A healthy 27-year-old Caucasian male had an uneventful donor evaluation for his mother, who had early onset ESKD of unclear cause. He participated in paired-exchange kidney donation, but developed progressive kidney disease and gout over the next 10 years. A uromodulin gene mutation (NM_003361.3(UMOD):c.377 G&gt;A p.C126Y) was detected and kidney biopsy showed tubulointerstitial kidney disease. The patient subsequently required kidney transplantation himself. Case 2 was a 36-year-old African American female who had an uneventful kidney donor evaluation. She underwent gene panel-based testing to rule out ApolipoproteinL1 risk variants, for which was negative. Incidentally, a sickle-cell trait (NM_000518.5(HBB):c.20A&gt;T p.Glu7Val) was noted, and she was declined for kidney donation. This led to significant patient anguish. Case 3 was a 26-year-old Caucasian female who underwent panel-based testing because the potential recipient, her cousin, carried a variant of uncertain significance in the hepatocyte nuclear factor-1-\u03b2 (HNF1B) gene. While the potential donor did not harbor this variant, she was found to have a likely pathogenic variant in complement factor I (NM_000204.4(CFI):c.1311dup:p.Asp438Argfs*8), precluding kidney donation. Our cases emphasize that while genetic testing can be invaluable in donor evaluation, transplant centers should utilize detailed informed consent, develop care pathways for secondary genetic findings, and share experience to develop best practices around genetic testing in donors.<\/jats:p>","DOI":"10.3390\/genes13040592","type":"journal-article","created":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T21:27:51Z","timestamp":1648416471000},"page":"592","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Vignette-Based Reflections to Inform Genetic Testing Policies in Living Kidney Donors"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-6763","authenticated-orcid":false,"given":"Gurmukteshwar","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Nephrology, Geisinger Health, Danville, PA 17822, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald","family":"Gohh","sequence":"additional","affiliation":[{"name":"Division of Organ Transplantation, Rhode Island Hospital, Providence, RI 02908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah","family":"Clark","sequence":"additional","affiliation":[{"name":"Natera, Inc., Austin, TX 78753, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Kalra","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Geisinger Health, Danville, PA 17822, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Geisinger Health, Danville, PA 17822, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitana","family":"Bradauskaite","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Einstein Medical Center, Philadelphia, PA 19141, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Bleyer","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2378-9302","authenticated-orcid":false,"given":"Bekir","family":"Tanriover","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of Arizona College of Medicine, Tucson, AZ 85719, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Geisinger Health, Danville, PA 17822, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7881-2162","authenticated-orcid":false,"given":"Prince M.","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Medical University of South Carolina, Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-Term Risks for Kidney Donors","volume":"86","author":"Hallan","year":"2014","journal-title":"Kidney Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of End-Stage Renal Disease Following Live Kidney Donation","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1681\/ASN.2016101084","article-title":"Quantifying Postdonation Risk of ESRD in Living Kidney DoSnors","volume":"28","author":"Massie","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/ajt.14678","article-title":"Risk of ESRD in Prior Living Kidney Donors","volume":"18","author":"Wainright","year":"2018","journal-title":"Am. J. Transpl."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e215718","DOI":"10.1001\/jamanetworkopen.2021.5718","article-title":"Association between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant","volume":"4","author":"Husain","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic Utility of Exome Sequencing for Kidney Disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.kint.2018.10.031","article-title":"Monogenic Causes of Chronic Kidney Disease in Adults","volume":"95","author":"Connaughton","year":"2019","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamapediatrics.2017.1755","article-title":"Diagnostic Impact and Cost-Effectiveness of Whole-Exome Sequencing for Ambulant Children with Suspected Monogenic Conditions","volume":"171","author":"Tan","year":"2017","journal-title":"JAMA Pediatr."},{"key":"ref_9","unstructured":"Wetterstrand, K.A. (2021, June 21). The Cost of Sequencing a Human Genome, Available online: https:\/\/www.genome.gov\/about-genomics\/fact-sheets\/Sequencing-Human-Genome-cost."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001770","article-title":"KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"ref_11","unstructured":"(2022, January 16). Organ Procurement and Transplantation Network. OPTN Policy 14.4.B, Available online: https:\/\/optn.transplant.hrsa.gov\/media\/eavh5bf3\/optn_policies.pdf."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/ajt.13970","article-title":"Screening of Living Kidney Donors for Genetic Diseases using a Comprehensive Genetic Testing Strategy","volume":"17","author":"Thomas","year":"2017","journal-title":"Am. J. Transpl."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lentine, K., Concepcion, B., and Lerma, E. (2021). Evaluation of Genetic Kidney Disease in Living Donor Candidates. Living Kidney Donation., Springer International Publishing.","DOI":"10.1007\/978-3-030-53618-3"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/TP.0000000000002933","article-title":"Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation","volume":"104","author":"Jay","year":"2020","journal-title":"Transplantation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/hmg\/ddaa114","article-title":"Effect of Rare Coding Variants in the CFI Gene on Factor I Expression Levels","volume":"29","author":"Volokhina","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jmg.39.12.882","article-title":"Mutations of the UMOD Gene are Responsible for Medullary Cystic Kidney Disease 2 and Familial Juvenile Hyperuricaemic Nephropathy","volume":"39","author":"Hart","year":"2002","journal-title":"J. Med. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/17474086.2017.1395279","article-title":"The Spectrum of Sickle Hemoglobin-Related Nephropathy: From Sickle Cell Disease to Sickle Trait","volume":"10","author":"Naik","year":"2017","journal-title":"Expert Rev. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2014.15063","article-title":"Association of Sickle Cell Trait with Chronic Kidney Disease and Albuminuria in African Americans","volume":"312","author":"Naik","year":"2014","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2016101086","article-title":"Sickle Cell Trait and the Risk of ESRD in Blacks","volume":"28","author":"Naik","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.kint.2020.03.031","article-title":"Genetic Testing for Kidney Disease of Unknown Etiology","volume":"98","author":"Hays","year":"2020","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for Reporting of Secondary Findings in Clinical Exome and Genome Sequencing, 2016 Update (ACMG SF V2.0): A Policy Statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41436-020-0810-9","article-title":"Frequency of Genomic Secondary findings among 21,915 eMERGE Network Participants","volume":"22","author":"Gordon","year":"2020","journal-title":"Genet. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Haga, S.B., Kim, E., Myers, R.A., and Ginsburg, G.S. (2019). Primary Care Physicians\u2019 Knowledge, Attitudes, and Experience with Personal Genetic Testing. J. Pers. Med., 9.","DOI":"10.3390\/jpm9020029"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2215\/CJN.15141219","article-title":"Clinical Genetic Screening in Adult Patients with Kidney Disease","volume":"15","author":"Cocchi","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/gim.2016.152","article-title":"A Survey of Current Practices for Genomic Sequencing Test Interpretation and Reporting Processes in US Laboratories","volume":"19","author":"McLaughlin","year":"2017","journal-title":"Genet. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.kint.2018.02.027","article-title":"A Kidney-Disease Gene Panel Allows a Comprehensive Genetic Diagnosis of Cystic And glomerular Inherited Kidney Diseases","volume":"94","author":"Bullich","year":"2018","journal-title":"Kidney Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41436-020-0772-y","article-title":"Initial Experience from a Renal Genetics Clinic Demonstrates a Distinct Role in Patient Management","volume":"22","author":"Thomas","year":"2020","journal-title":"Genet. Med."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/4\/592\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:44:05Z","timestamp":1760136245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/13\/4\/592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["genes13040592"],"URL":"https:\/\/doi.org\/10.3390\/genes13040592","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]}}}